Celestica has significantly raised its FY2026 adjusted EPS and sales guidance, with the new figures substantially exceeding current analyst estimates. This upward revision indicates strong confidence in future performance and is likely to be viewed very positively by the market.
Celestica announced a substantial increase in its FY2026 adjusted EPS guidance from $10.15 to $11.30, and its sales outlook from $19.000 billion to $20.500 billion. Both new figures are well above the current analyst estimates of $10.15 EPS and $19.180 billion in sales, respectively. This indicates a strong positive outlook from management, suggesting robust demand or improved operational efficiency. For traders, this presents a significant opportunity for short-term upside in CLS stock, as the market typically reacts favorably to such strong guidance beats. Long-term, it reinforces confidence in the company's growth trajectory and competitive position.